OpenAI has unveiled two new initiatives designed to strengthen biological defense and public health preparedness through artificial intelligence. The company is launching Rosalind Biodefense, a program that supports trusted organizations building biodefense applications, while also expanding access to GPT-Rosalind, its specialized life sciences reasoning model, for select government and public health partners.
The announcement reflects OpenAI’s broader strategy of what it calls “defensive acceleration” – using frontier AI capabilities to help organizations prevent, detect, and respond to biological threats. Through the new program, approved developers will receive sponsored access to GPT-Rosalind and support for building tools focused on areas such as epidemiological modeling, outbreak detection, diagnostics, preparedness planning, and medical countermeasure development.
OpenAI said the initiative is intended to help trusted organizations transform advanced AI capabilities into practical systems that improve resilience against both naturally occurring and engineered biological threats. Initial participants include organizations working on DNA synthesis screening, biosecurity detection systems, and biological threat prevention technologies.
The company is also extending trusted access to GPT-Rosalind for select U.S. government agencies and allied partners involved in public health and biodefense missions. These organizations will be able to apply the model to workflows including outbreak response planning, early warning systems, diagnostics, and vaccine development.
The announcement builds on OpenAI’s existing preparedness and safety efforts. The company said it has continued refining biological safeguards since introducing ChatGPT Agent in 2025, which it classified as a high-capability biology model under its Preparedness Framework. OpenAI has also worked with external evaluators, government agencies, and research institutions to assess biological risks and strengthen deployment safeguards.
Strengthening the Biodefense Ecosystem
The Rosalind Biodefense program reflects growing interest in applying AI to life sciences research and public health infrastructure. OpenAI believes advanced reasoning models can help researchers process scientific literature, design experiments, harmonize datasets, develop simulations, and support decision-making during health emergencies.
Among the organizations involved are Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, the Coalition for Epidemic Preparedness Innovations, and several biosecurity-focused startups. Their projects range from accelerating vaccine research and protein engineering to improving biological threat detection and countermeasure development.
By focusing on vetted organizations operating under trusted-access frameworks, OpenAI aims to expand beneficial use cases while maintaining oversight of higher-risk biological capabilities.
AI’s Expanding Role in Public Health
The announcement comes as AI companies increasingly explore applications beyond traditional chatbots and productivity tools. Life sciences, drug discovery, healthcare, and biosecurity have emerged as strategic areas where advanced AI systems could accelerate scientific progress and improve emergency response capabilities.
At the same time, these opportunities raise concerns about dual-use risks, where technologies capable of advancing beneficial biological research could potentially be misused. OpenAI said its approach combines broader access for qualified defenders with layered safeguards, including evaluations, monitoring, red teaming, and security controls.
The launch of Rosalind Biodefense signals a broader effort to position AI as a tool not only for scientific discovery but also for strengthening societal resilience. OpenAI said it expects to expand both the program and access to GPT-Rosalind over time as it continues working with public health agencies, research institutions, and biodefense organizations worldwide. The initiative follows other recent efforts focused on AI’s societal impact, including OpenAI Foundation’s commitment of an initial $250 million for research, grants, and programs designed to help workers and economies adapt to disruption caused by AI.
